Cambridge Academy of Therapeutic Sciences

A team of researchers at the University of Cambridge has identified a protein complex that might explain why some cancer patients treated with the revolutionary new anti-cancer drugs known as PARP inhibitors develop resistance to their medication. As we improve our understanding of these DNA repair networks and how they...

The Prince of Wales Global Sustainability Fellowship Programme represents a multi-million-pound commitment from the private sector to accelerate progress on UN Sustainable Development Goals. The Prince of Wales Global Sustainability Fellowship Programme will create a rich intellectual space for collaboration between...

The long-sought dream of wearable and mobile devices that will interpret, replicate and influence people’s emotions and perceptions will soon be a reality thanks to a collaboration between the University and Nokia Bell Labs. Nokia Bell Labs is a founding partner of the new Centre for Mobile, Wearable Systems and Augmented...

Business Secretary Greg Clark today announced funding for a series of ambitious technology projects that will transform the way medicines are discovered, enabling the pharmaceutical industry to develop groundbreaking drugs faster, cheaper and better than ever before. Our partnership in the institute gives us access to, and...

For women with HER2 positive early-stage breast cancer taking Herceptin for six months could be as effective as 12 months in preventing relapse and death, and can reduce side effects, finds new research. We are confident that this will mark the first steps towards a reduction of Herceptin treatment to six months in many...

The Body in Miniature The past few years has seen an explosion in the number of studies using organoids – so-called ‘mini organs’. While they can help scientists understand human biology and disease, some in the field have questioned their usefulness. But as the field matures, we could see their increasing use in...